108
Acknowledgements / Satellite Symposia
Monday, 23 June 2014
SA-02
SATELLITE SYMPOSIUM
12:15–13:45
Ballroom A
Predictive pharmacology – reductionism
and wishful thinking in antidepressant
development
SA-02-001
Introduction
Raymond Lam, Canada
SA-02-002
Antidepressant effects on cognitive func-
tion–from animal models to clinical trials
Roger McIntyre, Canada
SA-02-003
The neurocircuitry behind depression
Guy Manning Goodwin, United Kingdom
SA-02-004
Translating preclinical studies to improved
clinical outcomes in depression
Trevor Robbins, United Kingdom
supported by an unrestricted educational grant
from Lundbeck
SA-01
SATELLITE SYMPOSIUM
12:15–13:45
Ballroom B
New horizons in schizophrenia: Navigating
the evidence at the frontier of patient care
Chair:
William Honer, Canada
Chair:
Shitij Kapur, United Kingdom
SA-01-001
Charting advances in schizophrenia: Unmet
needs and new targets
William Honer, Canada
SA-01-002
Exploring the evidence: New treatment ap-
proaches in schizophrenia
W. Wolfgang Fleischhacker, Austria
SA-01-003
Anchoring emerging evidence to real world
clinical practice
Christoph Correll, USA
Satellite symposium sponsored by
F. Hoffmann-La Roche
SC-01
SCIENTIFIC SYMPOSIUM
17:15–18:45
Ballroom C
Stem cells and related epigenetic factors
in alcoholism
Chair:
Toshikazu Saito, Japan
Co-Chair: Julian Hellmann-Regen, Germany
SC-01-001
Altered retinoic acid homeostasis and mi-
croglial activation: Implications for neu-
ropsychiatric disorders and therapeutic
approaches
Julian Hellmann-Regen, Germany
SC-01-002
Our liver regeneration therapies using au-
tologous bone marrow derived cells for liver
cirrhosis
Taro Takami, Japan
SC-01-003
The role of neurogenesis in alcohol depen-
dence and metabolic disease
Dai-Jin Kim, Republic of Korea
SC-01-004
Stem cell therapy as a candidate treatment
approach for neural plasticity change in al-
cohol-induced brain damage and depression
Wataru Ukai, Japan
supported by an unrestricted educational grant
from Suntory
